For Biotech Takeovers, Timing is Key
TheStreet.com
Controversial JOBS Act Will Boost Biotech
Motley Fool
Biogen Idec: The Patriots of Biotechs
PharmExec
Biotechnology Funding Hits 4-Year High
Bloomberg
Submitted by moderatorj on Thu, 01/12/2012 - 00:00
Judge grants ex-Stryker Biotech exec's request to sever charges in fraud case
Submitted by moderatorj on Tue, 01/10/2012 - 23:55

